Vida has supported Aktis since co-leading its Series A, beginning with early platform diligence and company building efforts and continuing through multiple private financings and strategic inflection ...
Funding will accelerate development of first-in-class small-molecule drugs for a condition with no approved targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results